ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi, buoyed by Dupixent and rare disease drugs, expects a brighter 2019
February 24, 2019Sanofi’s growth momentum seems to have returned after years of diabetes-related decline. With a major contribution from Dupixent—plus some help from new blood disorder treatments added through recent acquisitions and a renewed focus on oncology—Sanofi is
Pharma Sources Insight January 2025
